Belpointe Asset Management LLC Lowers Position in Danaher Corporation $DHR

Belpointe Asset Management LLC cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 18.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,825 shares of the conglomerate’s stock after selling 888 shares during the quarter. Belpointe Asset Management LLC’s holdings in Danaher were worth $756,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of DHR. GHP Investment Advisors Inc. boosted its holdings in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the period. Sierra Ocean LLC boosted its holdings in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new position in Danaher during the 1st quarter valued at about $31,000. Dunhill Financial LLC boosted its holdings in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the period. Finally, Costello Asset Management INC purchased a new position in Danaher during the 1st quarter valued at about $41,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on DHR shares. Wells Fargo & Company lowered their target price on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. Barclays restated an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. UBS Group decreased their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Finally, Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research note on Friday, July 11th. Seventeen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $244.60.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of NYSE DHR opened at $205.13 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The firm has a market capitalization of $146.88 billion, a PE ratio of 43.64, a price-to-earnings-growth ratio of 2.97 and a beta of 0.77. The stock’s 50-day simple moving average is $200.41 and its 200-day simple moving average is $197.38.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the company earned $1.72 EPS. The business’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.